USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PRECLINOMICS, INC.
Address:
7918 ZIONSVILLE RD
INDIANAPOLIS, IN
Phone:
N/A
URL:
N/A
EIN:
352145759
DUNS:
129017112
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $296,394.00 2
SBIR Phase II $2,343,612.00 2

Award List:

Obese diabetic rat model w/o leptin/leptin-receptor defe

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$147,941.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): An estimated 18.2 million people (6.3 percent of the population) in the United States have diabetes; 90 to 95 percent of all diagnosed cases are type II diabetes (NIDDK, 2005). The search for new and more effective therapies to address the growing number of… More

Obese diabetic (type II) mouse model without leptin/leptin-receptor defects

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$148,453.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): An estimated 18.2 million people (6.3 percent of the population) in the United States have diabetes; 90 to 95 percent of all diagnosed cases are type II diabetes (NIDDK, 2005). Obesity and metabolic syndrome are the lea ding causes of type II diabetes. The search… More

Obese diabetic (type II) rat model without leptin/leptin-receptor defects

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$1,006,646.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): An estimated 18.2 million people (6.3 percent of the population) in the United States have diabetes; 90 to 95 percent of all diagnosed cases are type II diabetes (NIDDK, 2005). The search for new and more effective ther apies to address the growing number of… More

Obese diabetic (type II) mouse model without leptin/leptin-receptor defects

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,336,966.00
Agency:
HHS
Principal Investigator:
Richard G. Peterson – 317-872-6001
Abstract:
DESCRIPTION (provided by applicant): An estimated 23.6 million people (7 percent of the population) in the United States have diabetes; 90 to 95 percent of all diagnosed cases are type 2 diabetes (CDC, 2007). Obesity and metabolic syndrome are the leadingcauses of type 2 diabetes. The search for new… More